Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Raymond James

BioMarin Pharmaceutical Inc.
Start price
€63.66
10.10.24 / 50%
Target price
€72.21
10.10.25
Performance (%)
-28.37%
End price
€45.60
11.10.25
Summary
This prediction ended on 11.10.25 with a price of €45.60. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -28.37%. Raymond_James has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioMarin Pharmaceutical Inc. 5.138% 5.138% -19.321%
iShares Core DAX® 0,02 % 0,58 % 11,67 %
iShares Nasdaq 100 1,74 % -2,06 % 4,18 %
iShares Nikkei 225® 0,43 % 10,49 % 29,99 %
iShares S&P 500 1,33 % 0,14 % 3,33 %

Comments by Raymond_James for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -28.37%
Target price 72.214
Change
Ends at 10.10.25

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $79.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat

Raymond James 
0
Report Share
10.10.24
In the thread Trading BioMarin Pharmaceutical Inc.
Prediction Buy
Perf. (%) -28.37%
Target price 72.214
Change
Ends at 10.10.25

Die von Raymond_James gewählte maximale Laufzeit wurde überschritten

Raymond James 
0
Report Share
11.10.25

Current prediction by Raymond_James for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€51.00
03.09.25
€73.07
03.09.26
4.31%
24.02.26

Raymond James 
03.09.25 50%